Fundraising Fox

Boulder Ventures

Venture capitalActively deploying

Boulder · Series A · 6 people tracked

Also known as BVIM, LLC

Fox Verdict
Sign up to see your fit

Investment thesis

Boulder Ventures backs information technology and biotechnology companies concentrated in Colorado and the U.S. Mid-Atlantic region. Across its family of funds (Boulder Ventures I through VIII), the firm has invested in 61 companies, achieving 28 exits and 10 IPOs.

Source: firm website, verified Aug 25, 2026.

Stage
Series A
Check
$1M – $4M
HQ
Boulder, Colorado, US
Leads rounds
Leads
Instruments
Equity
Founded
1995
Last 12 months
1 investment
AUM
$400M
VC funds
8
Tracked investments
73

Team · 6 people

from the firm's website & public directories
Revelstoke the Berner· Floor Manager

Founder mafia

2 people who came through Boulder Ventures went on to found or lead other companies.

What they invest in

from 36 of 73 portfolio companies

Enterprise Software ×14SaaS ×14AI & Machine Learning ×10Biotech ×9Cloud Computing ×6Healthtech ×6Data & Infrastructure ×4Cybersecurity ×3

HQs:United States×29

Investments · 73 tracked

founders shown can be your intro path

By year:2026 · 12025 · 22024 · 12023 · 12022 · 22021 · 12018 · 12016 · 22015 · 42014 · 217 dated

miRagen TherapeuticsNASDAQ: VRDNFeb 2015SEC filingmedium confidence

Discovers and develops microRNA-targeting therapies for areas of high unmet medical need.

BiotechBoulder, US

William S. Marshall(Executive Officer, Director)Jason A. Leverone(Executive Officer)David Rodman(Executive Officer)Christopher J Morl(Executive Officer)Christopher Bowden(Director)Paul D. Rubin(Executive Officer)

Board seatKyle Lefkoff· per SEC Form D · $40.7M raise · filed Feb 2017

Co-investorsBrace PharmaMC Healthcare Ventures

Cogent Communicationscogentco.comin𝕏NASDAQ: CCOI

Cogent Communications is a facilities-based Internet Service Provider operating a multinational network across North America, Europe, Latin America, and Asia-Pacific.

Cloud ComputingData & InfrastructureEnterprise Software

Dave Schaeffer(Founder and Chief Executive Officer)

Co-investorsJerusalem Venture Partners (JVP)Norwest Venture PartnersOak Investment Partners

Mineralys Therapeuticsmineralystx.comin𝕏NASDAQ: MLYSJun 2022

Mineralys Therapeutics is a clinical-stage pharmaceutical company developing lorundrostat, a treatment targeting dysregulated aldosterone.

BiotechHealthtechRadnor, US

Eric Warren(Chief Commercial Officer)Alex Gold(Chief Medical Officer)Adam Levy(Executive Officer)Alexander Asam(Director)

BoardBrian Taylor Slingsby(Founder & former CEO / Board Director)Olivier Litzka(Director)in

Co-investorsAndera PartnersSamsara BioCapitalSR One Capital ManagementYsios CapitalCatalys PacificRA Capital

Onkure Therapeutics Inconkuretherapeutics.comin𝕏NASDAQ: OKUR

OnKure Therapeutics is a clinical-stage biopharmaceutical company developing PI3Kα pan-mutant selective inhibitor medicines for the treatment of breast cancer and vascular anomalies.

BiotechDigital HealthHealthtechMedical DevicesBoulder, US

Jason Leverone(Executive Officer)Samuel Agresta(Executive Officer)Dylan Hartley(Executive Officer)Nicholas Saccomano(Executive Officer, Director)Wendy Johnson(Executive Officer)

BoardIsaac Manke(Director)in

Co-investorsAccess BiotechnologyRiverVest Venture PartnersAbingworthACORN BIOVENTURESNew Enterprise Associates (NEA)

Ambrosia Biosciences Inc.Aug 2024

BiotechBoulder, US

Nicholas Traggis(Executive Officer, Director)

BoardDavid Snitman(Director)William S. Marshall(Director)John Orwin(Director)

Board seatKyle Lefkoff· per SEC Form D

Co-investorsBiotechnology Value Fund

ArcherDXarcherdx.comMar 2018

HealthtechBoulder, US

Jason Myers(Executive Officer, Director)Christian LaPointe(Executive Officer)

BoardPaul Manning(Director)in

Board seatKyle Lefkoff· per SEC Form D

Co-investorsCrawley VenturesLongwood FundPBM Capital

Bioptix DiagnosticsFeb 2015SEC filingmedium confidence

Boulder, US

Richard Whitcomb(Executive Officer, Director)

BoardDmitry Akhanov(Director)John Creecy(Director)Michael Routh(Director)William Marshall(Director)

Board seatKyle Lefkoff· per SEC Form D · $2.3M raise · filed Feb 2015

Black Bear Energyblackbearenergy.comin𝕏Jul 2016

Boulder, US

Andrew Torbin(Executive Officer, Director)

BoardHerv? Touati(Director)

Board seatKyle Lefkoff· per SEC Form D

ClosetboxApr 2016SEC filingmedium confidence

Denver, US

Marcus J. Mollmann(Executive Officer, Director)

BoardChristopher Roser(Director)Manish Vachharajani(Director)

Board seatPeter Roshko· per SEC Form D · $5M raise · filed Apr 2016

CommercialTribecommercialtribe.cominApr 2014

CommercialTribe is a Denver-based enterprise SaaS company offering video-based sales training and certification software.

Denver, US

Paul J. Ironside(Executive Officer, Director)Nathan Smalley(Executive Officer, Director)

BoardFrank Medicino(Director)Joseph R. Zell(Director)John Steward(Director)

Board seatKyle Lefkoff· per SEC Form D

Co-investorsAccess Venture PartnersCrawley VenturesAccess VenturesFirstMile VenturesGrotech Ventures

datAvaildatavail.comin𝕏Dec 2015

Datavail provides managed database administration, applications support, business intelligence, and process automation services for enterprise organizations.

AI & Machine LearningCloud ComputingData & InfrastructureEnterprise SoftwareSaaSBroomfield, US

Andrew Evans(Executive Officer)Mark Perlstein(Executive Officer, Director)Michael Jones(Director)David Boyle(Executive Officer)Andrew Morley(Director)Jeffrey Colvin(Director)

Board seatPeter Roshko· per SEC Form D

Co-investorsCatalyst InvestorsLead Edge Capital

Opangaopanga.comJun 2025

Opanga builds RAIN, an AI and machine learning network optimization platform for mobile network operators and communication service providers, providing real-time traffic optimization, network intelligence, and energy reduction.

AI & Machine LearningCleantechEnterprise SoftwareSeattle, US

Mary Dougherty(Executive Officer)Cole Brodman(Executive Officer, Director)Michael Targett(Executive Officer)Edward M. Salley(Member of the Board of Directors)Mary Frances Dougherty(Treasurer)William Michael Targett(Secretary)

Board seatKishen Mangat· per SEC Form D

Co-investorsCisco InvestmentsTrilogy Equity Partners

Spectrum Effect, Inc.Feb 2025SEC filingmedium confidence

Kirkland, US

Mary Dougherty(Executive Officer)Debby Toye(Executive Officer)Charles Immendorf(Executive Officer)Shaun McCarthy(Executive Officer)Mary Frances Dougherty(Executive Officer)Charles James Judson(Executive Officer)

Board seatKishen Mangat· per SEC Form D · $4.5M raise · filed Feb 2025

Synaptic Advisory PartnersinMay 2026SEC filingmedium confidence

Baltimore, US

Thomas Boosinger(Executive Officer, Director)William G. Karpovich(Executive Officer, Director)

BoardDavid Joubran(Director)

Board seatJonathan Perl· per SEC Form D · $3M raise · filed May 2026

247Realmedia247realmedia.com
Altheapbcaltheapbc.comin𝕏

Althea operates a platform that helps people find licensed psilocybin therapy facilitators in Oregon and Colorado, where psychedelic therapy is legal.

Digital HealthMarketplacesMental Health

Andrew Conley

Ambrosiabiosciencesambrosiabiosciences.comin

Ambrosia Biosciences is a drug discovery company developing orally delivered, small molecule therapies for obesity and other metabolic disorders.

BiotechHealthtechLongevity

Antithesisantithesis.comin𝕏

Antithesis provides deterministic simulation testing software that automatically finds and reproduces bugs in mission-critical software systems.

AI & Machine LearningDeveloper ToolsEnterprise SoftwareSaaS

Will Wilson(CEO & Co-Founder)inDave Scherer(Co-Founder)Nick Lavezzo(Founder)in

Co-investorsAmplify PartnersTamarack GlobalFrontline VenturesSpark CapitalTeamworthy VenturesWorldQuant Ventures+1 more

ARCA biopharmaarcabiopharma.cominJun 2015

BiotechWestminster, US

Michael R. Bristow(Executive Officer, Director)Thomas A. Keuer(Executive Officer)Brian L. Selby(Executive Officer)Christopher D. Ozeroff(Executive Officer)Richard B. Brewer(Director)Jean-Francois Formela(Director)

Arraybiopharmaarraybiopharma.comAcquired

Boulder-based biopharmaceutical company developing targeted small molecule cancer drugs; acquired by Pfizer in 2019.

Co-investorsARCH Venture Partners

ArrowPointcisco.comin𝕏Acquired

Cisco provides networking, data center, and security technology for enterprises, including infrastructure to run traditional and AI workloads and tools to keep organizations running against cyberattacks and outages.

Cloud ComputingCybersecurityEnterprise SoftwareIoTSan Jose, US

John ChambersinChuck Robbinsin

Co-investorsAccess Venture PartnersAllegisCyber CapitalAviv Venture CapitalBantam GroupCastile VenturesCeltic House Venture Partners+31 more

Barofoldbarofold.com
Bindviewbindview.com
Bioptixbioptix.com
Broadhopbroadhop.com
Centerstonetechcenterstonetech.com

Co-investorsCrawley Ventures

Clarabridgeclarabridge.com
Clean Republicclean-republic.comin

Clean Republic makes salt-based cleaning and wellness products built around hypochlorous acid (HOCl), an EPA-registered disinfectant made only from salt, water, and electricity.

ConsumerDirect to ConsumerWellness & Fitness

ClinOneclinone.comApr 2023 · $5M

Needham, US

Eric Schraufnagel(Founder)inAndrea Valente(Executive Officer, Director, Promoter)

BoardSteve Lindseth(Director)Bob Conway(Director)

Co-investorsJoyance PartnersNelstone VenturesSocial StartsCU Healthcare Innovation FundFirst Trust Capital Partners

Comeryxcomeryx.comin

Comeryx is an AI-native managing general agent (MGA) offering a fully digital platform for quoting, binding, and issuing Excess & Surplus insurance for small business artisan contractors.

AI & Machine LearningFintechInsurTech

Co-investorsAltai VenturesAmerican Family VenturesEchelonIntact Ventures

Dharmacondharmacon.comin𝕏

Dharmacon supplies functional genomics reagents — including synthetic oligonucleotides, siRNA for RNAi, and guide RNA for CRISPR-Cas9 gene editing and modulation — for researchers working at the DNA, RNA, and protein level.

BiotechDeep TechHealthtech

DMC Biotechnologiesdmcbio.comin𝕏

DMC Biotechnologies is a U.S.-based biomanufacturer that uses precision fermentation and its Dynamic Metabolic Control platform to produce bio-based specialty chemicals and ingredients, such as L-alanine and fermented inositols.

BiotechClimate TechNew MaterialsBoulder, US

Josh Yelen(Executive Officer)Josko Bobanovic(Director)K'Lynne Johnson(Director)Alastair Cooper(Director)Jim Flatt(Executive Officer, Director)Doug Cameron(Director)

Co-investorsBreakthrough Energy VenturesSofinnova PartnersCapricorn Venture Partners

Entelosentelos.com

Sam Holtzman(Founder)in

Co-investorsSofinnova Ventures

ERA Corporation
Everestsoftwareinceverestsoftwareinc.comin𝕏

The page provides only copyright and legal footer information referencing IgniteTech/ESW Capital Group, with no substantive description of the company's product or services.

Enterprise SoftwareAustin, US

Extensibility
Finalifinali.com
Flyby Media
Iluminilumin.com
iLumin Software Services
Intellinoteintellinote.net

Reston, US

William L Welch(Executive Officer, Director)Gene Sohn(Executive Officer, Director)Don Rainey(Director)Anthony Lopresti(Executive Officer, Director)

BoardJonathan Perl(Director)

Interlandinterland.net
InvoiceLink Corporation
Ksariaksaria.comin

kSARIA provides interconnect solutions, including connectors and cabling products, for the military and aerospace industry.

Advanced ManufacturingDefense TechHardware

LeftHand Networkslefthandnetworks.com

Co-investorsEPIC VENTURES

Lightdeckdxlightdeckdx.cominacquired by Antech Diagnostics

Digital HealthMedical Devices

Co-investorsEntrada Ventures

Lineratesystemslineratesystems.com
Marketforceinformationmarketforceinformation.com
Metron Aviationmetronaviation.comin𝕏

Metron Aviation builds air traffic flow management (ATFM) software for aviation authorities and air navigation service providers, including COMPASS, a global ATFM coordination platform, and Harmony for collaborative decision-making and management of traffic management initiatives.

Enterprise SoftwareMobility & TransportationSaaS

Miragenmiragen.comin𝕏

Miragen develops therapeutic programs for thyroid eye disease (TED), including an FcRn-focused portfolio, and supports clinical trials and patient education.

BiotechHealthtech

Morning Consult
Ng Voiceng-voice.comin

ng-voice builds a cloud-native, infrastructure-agnostic Hyperscale IMS (IP Multimedia Subsystem) software stack for producing voice services over 4G/5G networks, covering VoLTE, VoNR and VoWiFi for both consumer and IoT use cases.

Cloud ComputingDeep TechEnterprise Software

People Reignpeoplereign.ioin𝕏Dec 2021

PeopleReign develops AI-powered technology using natural language processing and machine learning to automate routine business processes for enterprise employees.

AI & Machine LearningEnterprise SoftwareFuture of WorkHR TechSan Jose, US

Dan Turchin(CEO)

BoardJonathan Perl(Director)in

Co-investorsAcadian Ventures Management, LlcJC2 VenturesMighty CapitalMoxxie VenturesSterling Road

Playmetricsplaymetrics.com

PlayMetrics offers an all-in-one club management software platform for youth soccer clubs, centralizing club management workflows in a single hub.

SaaSSports Tech

Co-investorsGenstar

Prostorsystemsprostorsystems.com𝕏
Rallydevelopmentrallydevelopment.com
Rannochrannoch.com
RapidFortrapidfort.comin𝕏Feb 2022 · $42M

RapidFort provides a software supply chain security platform that analyzes and hardens container images to eliminate vulnerabilities and reduce attack surface across development and production environments.

Cloud ComputingCybersecurityDeveloper ToolsSunnyvale, US

Mehran Farimani(CEO & Founder)inRuss Andersson(COO, Co-founder)inRajeev Thakur(CTO & Founder)inGeorge Manuelian(CRO, Co-founder)inRajeev T(Founder)

BoardRobert Mee(Director)

Co-investorsForgePoint CapitalCheyenne VenturesDelta-v CapitalEvolution VenturesFelicis VenturesFlorida Funders+7 more

Rapt Mediaraptmedia.cominJul 2014

SaaSBoulder, US

Tracey Riese(Director)Cameron McCaddon(Executive Officer, Director)Tim O'Neill(Director)Erika Trautman(Executive Officer, Director)Bart Lorang(Director)

Co-investorsTechstarsGolden Seeds

RedCloud Security

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.

Exits · 6

IPOs and acquisitions across the tracked portfolio

miRagen TherapeuticsNASDAQ: VRDNCogent CommunicationsNASDAQ: CCOIMineralys TherapeuticsNASDAQ: MLYSOnkure Therapeutics IncNASDAQ: OKURLightdeckdxacq. by Antech DiagnosticsYourekaacq. by Dispatch Technologies

Portfolio news

latest coverage across their companies

Frequently asked questions

How many investments has Boulder Ventures made?
Boulder Ventures has 16 tracked investments.
What stage does Boulder Ventures invest at?
Boulder Ventures invests at the Series A stage.
What is Boulder Ventures's typical check size?
Boulder Ventures typically writes checks of $1M – $4M.
What sectors does Boulder Ventures focus on?
Boulder Ventures focuses on AI & Machine Learning, Biotech, Cybersecurity, Data & Infrastructure, Developer Tools, Enterprise Software, Hardware, Healthtech, Medical Devices, SaaS, Sector Agnostic.
Where is Boulder Ventures located?
Boulder Ventures is headquartered in Boulder, US.
Does Boulder Ventures lead rounds?
Yes, Boulder Ventures leads investment rounds.
Who does Boulder Ventures co-invest with?
Boulder Ventures most often shares deals with Amplify Partners, Frontline Ventures, Mighty Capital, among 17 tracked co-investors.

From the blog

visit blog ↗

Boulder Ventures has written about founder readiness and market timing in startup success, concerns about AI company valuations amid a potential tech bubble, and the firm's team expertise and recent fund closing. AI summary

Similar investors

Featured in lists